A Phase 1, Open-label, Randomized, 3-Period, Relative Bioavailability Study Comparing the Pharmacokinetics of Granule and Tablet Formulations of Deferitazole (Disodium Salt) and a Capsule Formulation of Deferitazole (Magnesium Hydroxide Salt), Each Administered as a Single Oral Dose
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 19 Aug 2014
At a glance
- Drugs Deferitazole (Primary)
- Indications Iron overload
- Focus Pharmacokinetics
- Sponsors Shire
- 07 Aug 2014 Status changed from suspended to withdrawn prior to enrolment reported by ClinicalTrials.gov.
- 18 Mar 2014 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov record.
- 01 Mar 2014 New trial record